Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New sling aims to stop shoulder pain in stroke survivors

NCT ID NCT04028999

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a custom-made shoulder sling (EO31) in 25 adults who had a stroke within the last 6 months. The goal was to see if the sling could prevent shoulder pain and other complications. Researchers measured success using a goal-setting scale and pain scores. This is a small, early trial, so results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EO31 shoulder sling (custom-made shoulder support device)
What this could lead to
If effective, this sling could help prevent shoulder pain and complications after a stroke, improving recovery and quality of life.
What could go wrong
This is a very small, early study with only 25 participants and no comparison group. Results may not apply to all stroke survivors, and the sling may not prevent all shoulder issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

25 people

The number who actually took part.

Started

Jul 2019

Finished

Sep 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having suffered in the last 6 months maximum a first stroke responsible for hemiplegia. * Finding a clinical 5mm appendix, or with shoulder pain requiring prescription a scarf. * Boston Diagnostic Aphasia Examination (BDAE) \> 3. * Consent of the patient * Patient affiliated or benefiting from a social security scheme Exclusion Criteria: * Stroke recurrence, or stroke more than 6 months-old * Patient already wearing a coaptation scarf * Presence of lymphoedema, venous thrombosis of the upper limb * Neoprene allergy * Severe cognitive impairment: Mini-Mental State (MMS) \<15 * Patient being part of another care protocol * Adult under the protection of justice, tutors or curators * Pregnant or lactating woman.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebrovascular accident are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Toulouse

    Toulouse, 31000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.